Stay updated on Nivolumab in Resected Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.

Latest updates to the Nivolumab in Resected Esophageal Cancer Clinical Trial page
- Check6 days agoChange DetectedUpdated the revision label to v3.5.0 and removed the previous v3.4.3 entry.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded the NEJM 2021 CheckMate 577 publication citation; removed the Erratum reference.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedA new revision label v3.4.2 was added to the study documents, replacing the previous v3.4.1.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded the CheckMate 577 NEJM publication entry with full author list and erratum citation; removed the previous NEJM entry and updated the revision from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded new metadata/UI elements including a glossary toggle, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and revision v3.4.0. Removed older metadata fields: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and revision v3.3.4.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Resected Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.